BillionToOne, Inc.

BillionToOne, Inc. (BLLN) Stock Overview

Explore BillionToOne, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BLLNNASDAQ
HealthcareMedical - Diagnostics & Research
$127.60
$2.73(2.19%)
U.S. Market is Open · 15:18

BillionToOne, Inc. (BLLN)

Meyka AI Score

Z

Key Financials

Market Cap6B
P/E Ratio249.48
EPS (TTM)$0.55
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$107.38
3 Months$49.75
1 Year Target$82.36

BLLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BillionToOne, Inc. (BLLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.50, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $82.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 249.48 and a market capitalization of 6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.01%
5-Day Change
1.94%
1-Month Change
24.94%
3-Month Change
61.12%
6-Month Change
37.12%
Year-to-Date (YTD) Change
58.70%
1-Year Change
19.22%
3-Year Change
19.22%
5-Year Change
19.22%
All-Time (Max) Change
19.22%

Contact Information

(650) 460-2551
1035 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

6,200 Employees
IPO DateNov 6, 2025
CountryUS
Actively Trading

Frequently Asked Questions